Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003861 · ClinicalTrials.gov registry record
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
A clinical trial of Leukemia and Acute Lymphoblastic Leukemia, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- 840
- Enrollment target
- 20
- Study locations
NCT00003861: Active study of Leukemia and Acute Lymphoblastic Leukemia, sponsored by Alliance for Clinical Trials in Oncology.
NCT00003861 is a study of Leukemia and Acute Lymphoblastic Leukemia that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 840 participants, above the 483-participant average among 233 other Leukemia trials with a reported enrollment target (74% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003861, a study of Leukemia and Acute Lymphoblastic Leukemia, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- 840 participants
- Enrollment target
- 20
- Study locations
Study Summary
This research trial studies molecular genetic features in blood and tissue samples from patients with newly diagnosed acute lymphoblastic leukemia or acute promyelocytic leukemia. Studying samples of blood and tissue from patients with acute lymphoblastic leukemia or acute promyelocytic leukemia in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (20)
Maine
- Harold Alfond Center for Cancer Care - Augusta
- CancerCare of Maine at Eastern Maine Medical Center - Bangor
- Maine Center for Cancer Medicine and Blood Disorders - Scarborough - Scarborough
Massachusetts
- Massachusetts General Hospital - Boston
- Dana-Farber/Brigham and Women's Cancer Center - Boston
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute - Boston
California
- Naval Medical Center - San Diego - San Diego
- UCSF Helen Diller Family Comprehensive Cancer Center - San Francisco
Delaware
- Tunnell Cancer Center at Beebe Medical Center - Lewes
- CCOP - Christiana Care Health Services - Newark
Illinois
- University of Illinois Cancer Center - Chicago
- University of Chicago Cancer Research Center - Chicago
Maryland
- Greenebaum Cancer Center at University of Maryland Medical Center - Baltimore
- Union Hospital of Cecil County - Elkton
Missouri
- Ellis Fischel Cancer Center at University of Missouri - Columbia - Columbia
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis - St Louis
Florida
- Florida Hospital Cancer Institute at Florida Hospital Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 1999-04 |
What the registry record for NCT00003861 still lists
NCT00003861 is an observational study that tracks outcomes without assigning an intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, above the 483-participant average among 233 other Leukemia trials with a reported enrollment target (74% higher).
The record links to 3 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00003861 names 20 study sites across 11 states, led by Maine, Massachusetts, California.
Frequently Asked Questions
What is clinical trial NCT00003861 about?
NCT00003861 is a clinical study titled "Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia". This research trial studies molecular genetic features in blood and tissue samples from patients with newly diagnosed acute lymphoblastic leukemia or acute promyelocytic leukemia. Studying samples of blood and tissue from patients with acute lymphoblastic leukemia or acute promyelocytic leukemia in ...
What is the current status of trial NCT00003861?
This trial is currently active not recruiting. The enrollment target is 840 participants. The study started on 1999-04.
What conditions does trial NCT00003861 study?
This clinical trial studies the following conditions: Leukemia, Acute Lymphoblastic Leukemia, Acute Promyelocytic Leukemia.
What interventions are being tested in trial NCT00003861?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00003861?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00003861 being conducted?
This trial has 20 study locations across California, Delaware, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00003861's enrollment target sits among peer trials
840 11th of 233 higher than 223 of 233 other Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia